Stay updated on Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial

Sign up to get notified when there's something new on the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A notice about NIH websites transitioning from the term “artificial intelligence” to “super intelligence” appears above the 403 error page. The study record remains unavailable.
    Difference
    1%
    Check dated 2026-10-24T11:19:27.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T12:08:53.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer’s site revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T13:05:27.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The study details page now displays a 403 Forbidden error instead of the original content. This blocks users from viewing the trial's details and related information.
    Difference
    0.5%
    Check dated 2026-09-26T16:07:46.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content, showing the site branding and a minimal navigation. This indicates restricted access rather than an update to study data or page functionality.
    Difference
    20%
    Check dated 2026-09-19T18:55:54.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The page now includes a note about NIH grant/contract funding and the footer revision has been updated to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-29T19:05:24.000Z thumbnail image

Stay in the know with updates to Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page.